The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy

The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapy

BackgroundProgrammed death-ligand 1 (PD-L1) expression has been shown to be prognostic in many cancer types and used in consideration of checkpoint inhibitor immunotherapy. However, there are very limited and conflicting data on the prognostic impact of PD-L1 in patients with anal squamous cell carc...

Full description

Bibliographic Details
Main Authors: Angela MY. Chan, Gloria Roldan Urgoiti, Will Jiang, Sandra Lee, Elizabeth Kornaga, Peter Mathen, Rosanna Yeung, Emeka K. Enwere, Alan Box, Mie Konno, Martin Koebel, Kurian Joseph, Corinne M. Doll
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Oncology
Subjects:
anal cancer
PD-L1
CD8
chemoradiotherapy
immunotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1000263/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1000263/full

Similar Items